NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497 | -28.3% | 385 | 0.0% | 0.00% | – |
| Q2 2023 | $693 | +21.6% | 385 | 0.0% | 0.00% | – |
| Q1 2023 | $570 | -26.9% | 385 | -30.4% | 0.00% | – |
| Q4 2022 | $780 | -99.9% | 553 | +43.6% | 0.00% | – |
| Q3 2022 | $1,059,000 | -70.9% | 385 | -50.3% | 0.00% | – |
| Q2 2022 | $3,642,000 | +94.7% | 775 | +101.3% | 0.00% | – |
| Q1 2022 | $1,871,000 | -19.0% | 385 | 0.0% | 0.00% | – |
| Q4 2021 | $2,310,000 | -11.0% | 385 | 0.0% | 0.00% | – |
| Q3 2021 | $2,595,000 | -84.7% | 385 | -81.7% | 0.00% | – |
| Q2 2021 | $16,911,000 | -40.3% | 2,106 | -25.6% | 0.00% | – |
| Q1 2021 | $28,328,000 | -39.4% | 2,830 | -34.0% | 0.00% | – |
| Q4 2020 | $46,717,000 | +44.3% | 4,286 | +16.5% | 0.00% | – |
| Q3 2020 | $32,375,000 | +145.9% | 3,679 | +499.2% | 0.00% | – |
| Q2 2020 | $13,164,000 | -94.2% | 614 | -90.1% | 0.00% | – |
| Q1 2020 | $228,833,000 | +148.6% | 6,173 | +277.8% | 0.00% | – |
| Q4 2019 | $92,043,000 | +2015.9% | 1,634 | +1058.9% | 0.00% | – |
| Q3 2019 | $4,350,000 | +1971.4% | 141 | +907.1% | 0.00% | – |
| Q2 2019 | $210,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |